Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1381441665;41666;41667 chr2:178636131;178636130;178636129chr2:179500858;179500857;179500856
N2AB1217336742;36743;36744 chr2:178636131;178636130;178636129chr2:179500858;179500857;179500856
N2A1124633961;33962;33963 chr2:178636131;178636130;178636129chr2:179500858;179500857;179500856
N2B474914470;14471;14472 chr2:178636131;178636130;178636129chr2:179500858;179500857;179500856
Novex-1487414845;14846;14847 chr2:178636131;178636130;178636129chr2:179500858;179500857;179500856
Novex-2494115046;15047;15048 chr2:178636131;178636130;178636129chr2:179500858;179500857;179500856
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: K
  • RefSeq wild type transcript codon: AAG
  • RefSeq wild type template codon: TTC
  • Domain: Ig-88
  • Domain position: 35
  • Structural Position: 50
  • Q(SASA): 0.2596
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
K/R None None 0.235 N 0.25 0.15 0.146414634003 gnomAD-4.0.0 6.84457E-06 None None None None N None 0 0 None 0 0 None 0 0 8.09699E-06 0 1.65739E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
K/A 0.9927 likely_pathogenic 0.9916 pathogenic -0.912 Destabilizing 0.983 D 0.575 neutral None None None None N
K/C 0.983 likely_pathogenic 0.9829 pathogenic -0.945 Destabilizing 1.0 D 0.8 deleterious None None None None N
K/D 0.9986 likely_pathogenic 0.9984 pathogenic -0.244 Destabilizing 0.998 D 0.757 deleterious None None None None N
K/E 0.9824 likely_pathogenic 0.9807 pathogenic -0.126 Destabilizing 0.977 D 0.533 neutral N 0.495009172 None None N
K/F 0.9953 likely_pathogenic 0.9953 pathogenic -0.813 Destabilizing 1.0 D 0.802 deleterious None None None None N
K/G 0.9962 likely_pathogenic 0.9952 pathogenic -1.264 Destabilizing 0.998 D 0.686 prob.delet. None None None None N
K/H 0.8441 likely_pathogenic 0.8493 pathogenic -1.699 Destabilizing 0.999 D 0.723 deleterious None None None None N
K/I 0.9719 likely_pathogenic 0.9762 pathogenic 0.004 Stabilizing 0.998 D 0.805 deleterious None None None None N
K/L 0.9702 likely_pathogenic 0.9687 pathogenic 0.004 Stabilizing 0.995 D 0.686 prob.delet. None None None None N
K/M 0.9421 likely_pathogenic 0.943 pathogenic 0.027 Stabilizing 1.0 D 0.73 deleterious N 0.459405211 None None N
K/N 0.9921 likely_pathogenic 0.9911 pathogenic -0.62 Destabilizing 0.993 D 0.674 prob.neutral N 0.495009172 None None N
K/P 0.9995 likely_pathogenic 0.9993 pathogenic -0.273 Destabilizing 0.999 D 0.751 deleterious None None None None N
K/Q 0.8797 likely_pathogenic 0.8682 pathogenic -0.733 Destabilizing 0.993 D 0.663 prob.neutral N 0.42210314 None None N
K/R 0.2057 likely_benign 0.2007 benign -0.647 Destabilizing 0.235 N 0.25 neutral N 0.351319367 None None N
K/S 0.9964 likely_pathogenic 0.9957 pathogenic -1.377 Destabilizing 0.983 D 0.592 neutral None None None None N
K/T 0.9893 likely_pathogenic 0.988 pathogenic -1.043 Destabilizing 0.997 D 0.691 prob.delet. N 0.436816807 None None N
K/V 0.9607 likely_pathogenic 0.9664 pathogenic -0.273 Destabilizing 0.998 D 0.763 deleterious None None None None N
K/W 0.9911 likely_pathogenic 0.991 pathogenic -0.645 Destabilizing 1.0 D 0.765 deleterious None None None None N
K/Y 0.976 likely_pathogenic 0.9751 pathogenic -0.311 Destabilizing 0.999 D 0.786 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.